Postural orthostatic tachycardia syndrome

Postgraduate Medical Journal

Volumn 83, Issue 981, 2007, Pages 478-480

  Agarwal, Anil K ^a   Garg, R ^b   Ritch, A ^a   Sarkar, P ^a  

^a CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMFEBUTAMONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DULOXETINE; ERYTHROPOIETIN; FLUDROCORTISONE; LABETALOL; METHYLPHENIDATE; MIDODRINE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; PHENOTHIAZINE DERIVATIVE; PYRIDOSTIGMINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

AEROBIC EXERCISE; BLOOD PRESSURE; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MECHANISM; HISTORY OF MEDICINE; HUMAN; MEDICAL ASSESSMENT; MONOTHERAPY; ORTHOSTATIC HYPOTENSION; PULSE RATE; REVIEW; SINUS TACHYCARDIA; TACHYCARDIA; TREATMENT OUTCOME;

DIAGNOSIS, DIFFERENTIAL; FATIGUE SYNDROME, CHRONIC; HUMANS; POSTURE; SYNDROME; TACHYCARDIA;

EID: 34547211740     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2006.055046     Document Type: Review

References (29)

1. Grubb BP, Kosinski DJ, Boehm K, et al. The postural orthostatic tachycardia syndrome: a neurocardiogenic variant identified during head-up tilt table testing. Pacing Clin Electrophysiol 1997;20(9 Pt 1):2205-12.
2. Karas B, Grubb BP, Boehm K, et al. The postural orthostatic tachycardia syndrome: a potentially treatable cause of chronic fatigue, exercise intolerance, and cognitive impairment in adolescents. Pacing Clin Electrophysiol 2000;23:344-51.
3. Low PA, Schondorf R, Rummans TA. Why do patients have orthostatic symptoms in POTS? Clin Auton Res 2001;11:223-4.
4. Robertson D, Shannon JR, Biaggioni I, et al. Orthostatic intolerance and the postural tachycardia syndrome: genetic and environment pathophysiologies. Neurolab Autonomic Team. Pflugers Arch 2000;441(2-3 Suppl):R48-51.
5. Frohlich ED, Dustan HP, Tarazi RC. Hyperdynamic beta-adrenergic circulatory state. An overview. Arch Intern Med 1970;126:1068-9.
6. Kanjwal Y, Kosinski D, Grubb BP. The postural orthostatic tachycardia syndrome: definitions, diagnosis, and management. Pacing Clin Electrophysiol 2003;26:1747-57.
7. Stober G, Nothen MM, Porzgen P, et al. Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders. Am J Med Genet 1996;67:523-32.
8. Fouad FM, Tadena-Thome L, Bravo EL, et al. Idiopathic hypovolemia. Ann Intern Med 1986;104:298-303.
9. Pasternac A, Tubau JF, Puddu PE, et al. Increased plasma catecholamine levels in patients with symptomatic mitral valve prolapse. Am J Med 1982;73:783-90.
10. Jacob G, Robertson D, Mosqueda-Garcia R, et al. Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system. Am J Med 1997;103:128-33.
11. Streeten DH, Anderson GH Jr, Richardson R, et al. Abnormal orthostatic changes in blood pressure and heart rate in subjects with intact sympathetic nervous function: evidence for excessive venous pooling. J Lab Clin Med 1988;111:326-35.
12. Muenter Swift N, Charkoudian N, Dotson RM, et al. Baroreflex control of muscle sympathetic nerve activity in postural orthostatic tachycardia syndrome. Am J Physiol Heart Circ Physiol 2005;289:H1226-33.
13. Low PA, Caskey PE, Tuck RR, et al. Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol 1983;14:573-80.
14. Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology 1993;43:132-7.
15. Grubb BP, Kosinski DJ, Kanjwal Y. Orthostatic hypotension: causes, classification, and treatment. Pacing Clin Electrophysiol 2003;26(4 Pt 1):892-901.
16. Goldstein DS, Eldadah B, Holmes C, et al. Neurocirculatory abnormalities in chronic orthostatic intolerance. Circulation 2005;111:839-45.
17. Furlan R, Jacob G, Snell M, et al. Chronic orthostatic intolerance: a disorder with discordant cardiac and vascular sympathetic control. Circulation 1998;98:2154-9.
18. Rowe PC, Bou-Holaigah I, Kan JS, et al. Is neurally mediated hypotension an unrecognised cause of chronic fatigue? Lancet 1995;345:623-4.
19. Stewart JM, Gewitz MH, Weldon A, et al. Orthostatic intolerance in adolescent chronic fatigue syndrome. Pediatrics 1999;103:116-21.
20. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994;121:953- 9.
21. Grubb BP. Dysautonaumic syncope. In: Grubb BP, Olshansky B, eds. Syncope:mechanisms and management. Armonk, New York: Futura Press, 1988:107-26.
22. Freitas J, Santos R, Azevedo E, et al. Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone. Clin Auton Res 2000;10:293-9.
23. Grubb BP, Karas B, Kosinski D, et al. Preliminary observations on the use of midodrine hydrochloride in the treatment of refractory neurocardiogenic syncope. J Interv Card Electrophysiol 1999;3:139-43.
24. Grubb BP, Kosinski D, Mouhaffel A, et al. The use of methylphenidate in the treatment of refractory neurocardiogenic syncope. Pacing Clin Electrophysiol 1996;19:836-40.
25. Grubb BP, Karas B. Preliminary observations on the use of erythropoietin in the treatment of refractory postural tachycardia syndrome. Clin Auton Res 1999;9:228.
26. Vincent S, Bieck PR, Garland EM, et al. Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles. Circulation 2004;109:3202-7.
27. Schroeder C, Tank J, Boschmann M, et al. Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance. Circulation 2002;105:347-53.
28. Grubb BP, Karas BJ. The potential role of serotonin in the pathogenesis of neurocardiogenic syncope and related autonomic disturbances. J Interv Card Electrophysiol 1998;2:325-32.
29. Raj SR, Black BK, Biaggioni I, et al. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation 2005;111:2734-40.